Available to mentor
Dr. Marci Lesperance is the associate chief clinical officer for Children’s Specialty and Women’s Services, University of Michigan Medical Group. She served as the division chief of Pediatric Otolaryngology at Michigan Medicine for 15 years. Her research has been funded by NIH and outside foundations. She has previously served as surgeon in chief for the Children’s and Women’s Hospital, program director for the University of Michigan’s Pediatric Otolaryngology Fellowship, and past president of the American Society of Pediatric Otolaryngology. She currently serves as the pediatric otolaryngology section editor for Cummings Otolaryngology-Head and Neck Surgery, 6th and 7th editions.
Lesperance grew up in Northville, Michigan and attended Detroit Country Day High School. As the oldest of four children of a nurse and an engineer, she was always drawn to science and children. She received her medical degree at the University of Michigan Medical School (1988), completed her residency in otolaryngology-head and neck surgery at the University of Michigan Health System (1994) and a fellowship in pediatric otolaryngology at the Children's National Medical Center (1996).
Through medical school at the University of Michigan, Lesperance had the opportunity to work with the renowned faculty in the otolaryngology department. She was attracted to otolaryngology by the opportunity to be an expert in the head and neck, which involves critical senses and functions such as hearing and breathing. She devotes her practice to pediatric otolaryngology for the privilege of interacting with children and their parents and help the children overcome illnesses so that they can grow and achieve their best potential.
-
MSUniversity of Michigan, Ann Arbor, 1991
-
MDUniversity of Michigan, Ann Arbor, 1988
-
BSUniversity of Michigan, Ann Arbor, 1986
-
Center MemberKresge Hearing Research Institute
Dr. Marci Lesperance's research interests include hereditary hearing loss, molecular genetics of hearing loss and genetic testing.
-
Lesperance MM. 2021 Jan 1; 1 - 577.BookCummings Pediatric Otolaryngology
DOI:10.1016/B978-0-323-69618-0.01001-5 -
Lesperance MM, Malloy K. 2021Additional ScholarshipExpanding Your Career Options: Clinical Leadership
-
Freeman AT, Lesperance M, Wai ES, Croteau NS, Fiorino L, Geller G, Brooks EG, Poonja Z, Fenton D, Irons S, Ksienski D. Curr Oncol, 2020 Apr; 27 (2): 76 - 82.Journal ArticleTreatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab.
DOI:10.3747/co.27.5495 PMID: 32489249 -
2019 Jun 1;Presentation"Tongue tip and lip tie: myths, facts, and treatment options"
-
2019 Mar 1;PresentationInvited Moderator: Pediatric Salivary Disorders
-
Murchison SC, Wiksyk B, Gossman S, Jensen B, Sayers D, Lesperance M, Truong PT, Alexander A. Cureus, 2018 Nov 21; 10 (11): e3618Journal ArticleSubventricular Zone Radiation Dose and Outcome for Glioblastoma Treated Between 2006 and 2012.
DOI:10.7759/cureus.3618 PMID: 30697499 -
Tyler S, Truong PT, Lesperance M, Nichol A, Baliski C, Warburton R, Tyldesley S. Int J Radiat Oncol Biol Phys, 2018 Jul 1; 101 (3): 661 - 670.Journal ArticleClose Margins Less Than 2 mm Are Not Associated With Higher Risks of 10-Year Local Recurrence and Breast Cancer Mortality Compared With Negative Margins in Women Treated With Breast-Conserving Therapy.
DOI:10.1016/j.ijrobp.2018.03.005 PMID: 29678525 -
Lesperance MM, Winkler E, Melendez TL, Yashar BM. J Genet Couns, 2018 Jun; 27 (3): 597 - 607.Journal Article"My Plate is Full": Reasons for Declining a Genetic Evaluation of Hearing Loss.
DOI:10.1007/s10897-017-0149-9 PMID: 28980162